Skip to main content
. Author manuscript; available in PMC: 2011 Oct 9.
Published in final edited form as: Arch Intern Med. 2007 Nov 12;167(20):2213–2219. doi: 10.1001/archinte.167.20.2213

Table 2.

A Comparison of Cystatin C Level and Creatinine Level as Measures of Kidney Function in HIV-Infected and Control Participants

Measure of Kidney Function HIV-Infected
Individuals
(n=519)
Controls
(n=290)
P
Value
Cystatin C, mean±SD, mg/L 0.92±0.22 0.76±0.15 <.001
 Unadjusted difference (95% CI)a 0.16 (0.14 to 0.19) <.001
 Adjusted difference (95% CI)a,b 0.11 (0.08 to 0.14) <.001
Cystatin C >1.0 mg/L, No. (%) 156 (31) 11 (4) <.001
 Unadjusted OR (95% CI)a 10.8 (5.7 to 20.2) <.001
 Adjusted OR (95% CI)a,b 9.8 (4.4 to 22.0) <.001
Creatinine, mean±SD, mg/dL 0.87±0.21 0.85±0.19 .35
 Unadjusted difference (95% CI)a 0.02 (−0.01 to 0.05) .19
 Adjusted difference (95% CI)a,b 0.00 (−0.03 to 0.03) .78
eGFR, mean±SD, mL/min/1.73 m2 110±26 106±23 .06
 Unadjusted difference (95% CI)a 4 (0 to 7) .04
 Adjusted difference (95% CI)a,b 2 (−2 to 7) .35
eGFR <75 mL/min/1.73 m2, No. (%) 28 (5) 13 (4) .62
 Unadjusted OR (95% CI)a 1.22 (0.62 to 2.39) .57
 Adjusted OR (95% CI)a,b 1.28 (0.56 to 2.92) .55

Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; HIV, human immunodeficiency virus; OR, odds ratio.

SI conversion factor: To convert creatinine to micromoles per liter, multiply by 88.4.

a

Participants with HIV vs controls.

b

Sex, age, and ethnicity were included in all models; other candidate variables were selected by a stepwise procedure.